These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10577673)

  • 1. CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy.
    Buzzetti R; Nisticò L; Signore A; Cascino I
    Lancet; 1999 Nov; 354(9192):1824. PubMed ID: 10577673
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy.
    Vaidya B; Imrie H; Perros P; Dickinson J; McCarthy MI; Kendall-Taylor P; Pearce SH
    Lancet; 1999 Aug; 354(9180):743-4. PubMed ID: 10475192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunogenetics of thyroid-associated orbitopathy.
    Weetman AP; Hunt PJ
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S149-51. PubMed ID: 10614909
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease.
    Zaletel K; Krhin B; Gaberscek S; Pirnat E; Hojker S
    Thyroid; 2002 May; 12(5):373-6. PubMed ID: 12097196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
    Heward JM; Allahabadia A; Armitage M; Hattersley A; Dodson PM; Macleod K; Carr-Smith J; Daykin J; Daly A; Sheppard MC; Holder RL; Barnett AH; Franklyn JA; Gough SC
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2398-401. PubMed ID: 10404810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of Graves disease.
    Chistyakov DA; Savost'anov KV; Turakulov RI; Nosikov VV
    Mol Genet Metab; 2000; 71(1-2):66-9. PubMed ID: 11001797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
    Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
    Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population.
    Yanagawa T; Hidaka Y; Guimaraes V; Soliman M; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Jan; 80(1):41-5. PubMed ID: 7829637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of Graves' disease.
    Gough SC
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):255-66. PubMed ID: 10874528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptible alleles of the CD40 and CTLA-4 genes are not associated with the relapse after antithyroid withdrawal in Graves' disease.
    Kim KW; Park YJ; Kim TY; Park DJ; Park KS; Cho BY
    Thyroid; 2007 Dec; 17(12):1229-34. PubMed ID: 17949264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
    Hadj Kacem H; Bellassoued M; Bougacha-Elleuch N; Abid M; Ayadi H
    Clin Immunol; 2001 Dec; 101(3):361-5. PubMed ID: 11726229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism.
    Kotsa K; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 1997 May; 46(5):551-4. PubMed ID: 9231050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex association analysis of graves disease using a set of polymorphic markers.
    Chistyakov DA; Savost'anov KV; Turakulov RI; Petunina NA; Trukhina LV; Kudinova AV; Balabolkin MI; Nosikov VV
    Mol Genet Metab; 2000 Jul; 70(3):214-8. PubMed ID: 10924276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aetiology of Graves' disease: what is the genetic contribution?
    Philippou G; McGregor AM
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):393-5. PubMed ID: 9640403
    [No Abstract]   [Full Text] [Related]  

  • 15. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
    Allahabadia A; Heward JM; Nithiyananthan R; Gibson SM; Reuser TT; Dodson PM; Franklyn JA; Gough SC
    Lancet; 2001 Sep; 358(9286):984-5. PubMed ID: 11583755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07.
    Kula D; Bednarczuk T; Jurecka-Lubieniecka B; Polanska J; Hasse-Lazar K; Jarzab M; Steinhof-Radwanska K; Hejduk B; Zebracka J; Kurylowicz A; Bar-Andziak E; Stechly T; Pawlaczek A; Gubala E; Krawczyk A; Szpak-Ulczok S; Nauman J; Jarzab B
    Thyroid; 2006 May; 16(5):447-53. PubMed ID: 16756466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population.
    Awata T; Kurihara S; Iitaka M; Takei S; Inoue I; Ishii C; Negishi K; Izumida T; Yoshida Y; Hagura R; Kuzuya N; Kanazawa Y; Katayama S
    Diabetes; 1998 Jan; 47(1):128-9. PubMed ID: 9421386
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
    Agarwal K; Czaja AJ; Jones DE; Donaldson PT
    Hepatology; 2000 Jan; 31(1):49-53. PubMed ID: 10613727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.
    Alizadeh M; Babron MC; Birebent B; Matsuda F; Quelvennec E; Liblau R; Cournu-Rebeix I; Momigliano-Richiardi P; Sequeiros J; Yaouanq J; Genin E; Vasilescu A; Bougerie H; Trojano M; Martins Silva B; Maciel P; Clerget-Darpoux F; Clanet M; Edan G; Fontaine B; Semana G
    Ann Neurol; 2003 Jul; 54(1):119-22. PubMed ID: 12838528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic dissection of familial autoimmune thyroid diseases using whole genome screening.
    Tomer Y
    Autoimmun Rev; 2002 Aug; 1(4):198-204. PubMed ID: 12848996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.